Cargando…
Development and novel therapeutics in hepatocellular carcinoma: a review
This review summarizes the epidemiological trend, risk factors, prevention strategies such as vaccination, staging, current novel therapeutics, including the drugs under clinical trials, and future therapeutic trends for hepatocellular carcinoma (HCC). As HCC is the third most common cause of cancer...
Autores principales: | Ingle, Pravinkumar Vishwanath, Samsudin, Sarah Zakiah, Chan, Pei Qi, Ng, Mei Kei, Heng, Li Xuan, Yap, Siu Ching, Chai, Amy Siaw Hui, Wong, Audrey San Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801152/ https://www.ncbi.nlm.nih.gov/pubmed/27042086 http://dx.doi.org/10.2147/TCRM.S92377 |
Ejemplares similares
-
Relationship between Treatment Burden, Health Literacy, and Medication Adherence in Older Adults Coping with Multiple Chronic Conditions
por: Selvakumar, Dharrshinee, et al.
Publicado: (2023) -
STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
por: Lee, Carol, et al.
Publicado: (2019) -
Cellular Senescence: Mechanisms and Therapeutic Potential
por: Liao, Zehuan, et al.
Publicado: (2021) -
A data-driven machine learning approach for discovering potent LasR inhibitors
por: Koh, Christabel Ming Ming, et al.
Publicado: (2023) -
Epidemiological risk factors for adult dengue in Singapore: an 8-year nested test negative case control study
por: Yung, Chee Fu, et al.
Publicado: (2016)